This column is a nod to my former role as the 17th director of the NCI,” writes W. Kimryn Rathmell. “It was the greatest honor of my career. This column is a love letter of sorts to our field, a recognition of all that we have accomplished and an acknowledgement that we need to find a path forward that supports and empowers the best of what it is to invest in cancer research.